Ignite Creation Date:
2025-12-24 @ 9:20 PM
Ignite Modification Date:
2026-01-22 @ 12:20 PM
Study NCT ID:
NCT04088604
Status:
COMPLETED
Last Update Posted:
2023-04-26
First Post:
2019-08-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
Sponsor:
Luye Pharma Group Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-22
First Submit QC Date:
None
Study First Post Date:
2019-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-25
Last Update Post Date:
2023-04-26
Last Update Post Date Type:
ACTUAL